Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma.

Diffuse large B cell lymphoma (DLBCL) is the most common lymphoma subtype and is clinically aggressive. To identify genetic susceptibility loci for DLBCL, we conducted a meta-analysis of 3 new genome-wide association studies (GWAS) and 1 previous scan, totaling 3,857 cases and 7,666 controls of European ancestry, with additional genotyping of 9 promising SNPs in 1,359 cases and 4,557 controls. In our multi-stage analysis, five independent SNPs in four loci achieved genome-wide significance marked by rs116446171 at 6p25.3 (EXOC2; P = 2.33 × 10⁻²¹), rs2523607 at 6p21.33 (HLA-B; P = 2.40 × 10⁻¹⁰), rs79480871 at 2p23.3 (NCOA1; P = 4.23 × 10⁻⁸) and two independent SNPs, rs13255292 and rs4733601, at 8q24.21 (PVT1; P = 9.98 × 10⁻¹³ and 3.63 × 10⁻¹¹, respectively). These data provide substantial new evidence for genetic susceptibility to this B cell malignancy and point to pathways involved in immune recognition and immune function in the pathogenesis of DLBCL. [ABSTRACT FROM AUTHOR]